Holding the Third-Party Litigation Financing Industry Accountable: AdvaMed Urges Congressional Reform to Protect Patients and Innovation
Washington, D.C. – The U.S. House Oversight Committee held a hearing on September 13, 2023, to address the concerns surrounding third-party litigation financing. AdvaMed and its members have expressed significant worries about the impact of these financing practices. They argue that third-party speculators, along with the attorneys they fund, are taking advantage of the mass tort litigation system, prioritizing their own financial gain over the well-being of patients, medical device manufacturers, and the general public. By investing substantial amounts into advertising campaigns, these attorneys and financial backers can generate a large number of cases, many … Read more